Insider Transactions in Q2 2023 at Inovio Pharmaceuticals, Inc. (INO)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Michael John Sumner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+50.0%
|
-
|
|
Jun 05
2023
|
Lota S. Zoth Director |
SELL
Open market or private sale
|
Direct |
5,700
-9.76%
|
$0
$0.56 P/Share
|
|
May 16
2023
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+2.0%
|
-
|
|
May 16
2023
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+20.4%
|
-
|
|
May 16
2023
|
Lota S. Zoth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+24.54%
|
-
|
|
May 16
2023
|
Ann Calby Miller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+22.21%
|
-
|
|
May 16
2023
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+16.77%
|
-
|
|
May 16
2023
|
Jay Shepard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+24.51%
|
-
|
|
May 16
2023
|
Roger D Dansey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+30.65%
|
-
|
|
May 13
2023
|
Roger D Dansey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+33.33%
|
-
|
|
May 10
2023
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,704
-12.66%
|
$0
$0.81 P/Share
|
|
May 10
2023
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
66,000
+22.54%
|
-
|